Abstract
A selection of cases showing various benign and malignant presentation in pediatric age group.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSuggested Reading
Agrawal K, Mittal B, Harisankar C, Kuruva M, Bhattacharya A, Bansal D, Trehan A, Marwaha RK. Can F-18 FDG PET/CT avoid bone marrow biopsy in pediatric Hodgkin’s lymphoma? India J Nucl Med. 2011;52 Suppl 1:399.
Aide N, Cappele O, Bottet P, Bensadoun H, Regeasse A, Comoz F, Sobrio F, Bouvard G, Agostini D. Efficiency of [(18)F] FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT. Eur J Nucl Med Mol Imaging. 2003;30(9):1236–45.
Ak I, Can C. F-18 FDG PET in detecting renal cell carcinoma. Acta Radiol. 2005;46(8):895–9.
Becherer A, Vierhapper H, Pötzi C, Karanikas G, Kurtaran A, Schmaljohann J, Staudenherz A, Dudczak R, Kletter K. FDG-PET in adrenocortical carcinoma. Cancer Biother Radiopharm. 2001;16(4):289–95.
Bestic JM, Peterson JJ, Bancroft LW. Use of FDG PET in staging, restaging, and assessment of therapy response in Ewing sarcoma. RadioGraphics. 2009;29:1487–500.
Brink I, Reinhardt MJ, Hoegerle S, Altehoefer C, Moser E, Nitzsche EU. Increased metabolic activity in the thymus gland studied with 18F-FDG PET: age dependency and frequency after chemotherapy. J Nucl Med. 2001;42(4):591–5.
Choi JY, Lee KS, Kim H-J, Shim YM, Kwon OJ, Park K, Baek C-H, Chung JH, Lee K-H, Kim B-T. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization. J Nucl Med. 2006;4:609–15.
Clarke JR, Brglevska S, Lau EW, Ramdave S, Hicks RJ. Atypical brown fat distribution in young males demonstrated on PET/CT. Clin Nucl Med. 2007;32(9):679–82.
Coccia P, Ruggiero A, Rufini V, Maurizi P, Attiná G, Riccardo M, Natale L, Leccisotti L, Calcagni ML, Riccardi R. Cardiac metastases of Ewing sarcoma detected by 18F-FDG PET/CT. J Pediatr Hematol/Oncol. 2012;34(3):236–8.
Delbeke D, Martin W. Update of PET and PET/CT for hepatobiliary and pancreatic malignancies. HBP. 2005;7(3):166–79.
Freudenberg LS, Antoch G, Jentzen W, Pink R, Knust J, Görges R, Müller SP, Bockisch A, Debatin JF, Brandau W. Value of 124I-PET/CT in staging of patients with differentiated thyroid cancer. Eur Radiol. 2004;14:2092–8.
Gawande RS, Khurana A, Messing S, Zhang D, Castañeda RT, Goldsby RE, Hawkins RA, Daldrup-Link HE. Differentiation of normal thymus from anterior mediastinal lymphoma and lymphoma recurrence at pediatric PET/CT. Radiology. 2012;262(2):613–22.
Groves AM, Win T, Screaton NJ, Berovic M, Endozo R, Booth H, Kayani I, Menezes LJ, Dickson JC, Ell PJ. Idiopathic pulmonary fibrosis and diffuse parenchymal lung disease: implications from initial experience with 18F-FDG PET/CT. J Nucl Med. 2009;50(4):538–45.
Hernandez-Pampaloni M, Takalkar A, Yu JQ, Zhuang H, Alavi A. F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas. Pediatr Radiol. 2006;36(6):524–31.
Hudson MM, Krasin MJ, Kaste SC. PET imaging in pediatric Hodgkin’s lymphoma. Pediatr Radiol. 2004;34(3):190–8.
Inoue K, Okada K, Taki Y, Goto R, Kinomura S, Fukuda H. (18)FDG uptake associated with CT density on PET/CT in lungs with and without chronic interstitial lung diseases. Ann Nucl Med. 2009;23(3):277–81.
Jadvar H, Fischman AJ. Evaluation of rare tumors with [F-18]Fluorodeoxyglucose positron emission tomography. Clin Positron Imaging. 1999;2(3):153–8.
Kabickova E, Sumerauer D, Cumlivska E, Drahokoupilova E, Nekolna M, Chanova M, Hladikova M, Kodet R, Belohlavek O. Comparison of 18F-FDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkin’s disease. Eur J Nucl Med Mol Imaging. 2006;33(9):1025–31.
Kaneta T, Hakamatsuka T, Yamada T, Takase K, Sato A, Higano S, Kinomura S, Fukuda H, Takahashi S, Yamada S. Case Report: FDG PET in solitary metastastic/secondary tumor of the kidney: a report of three cases and a review of the relevant literature. Ann Nucl Med. 2006;20(1):79–82.
London K, Cross S, Onikul E, Dalla-Poza L, Howman-Giles R. 18F-FDG PET/CT in paediatric lymphoma: comparison with conventional imaging. Eur J Nucl Med Mol Imaging. 2011;38(2):274–84.
Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97–109.
Lucas JD, O’Doherty MJ, Wong JC, Bingham JB, McKee PH, Fletcher CD, Smith MA. Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas. J Bone Joint Surg Br. 1998;80(3):441–7.
Ludwig JA. Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future. Curr Opin Oncol. 2008;20(4):412–8.
Mackie GC, Shulkin BL, Ribeiro RC, Worden FP, Gauger PG, Mody RJ, Connolly LP, Kunter G, Rodriguez-Galindo C, Wallis JW, Hurwitz CA, Schteingart DE. Use of [18F]Fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma. J Clin Endocrine Metab. 2006;91:2665–71.
Makis W, Lisbona R, Derbekyan V. Hodgkin lymphoma post-transplant lymphoproliferative disorder following pediatric renal transplant: serial imaging with F-18 FDG PET/CT. Clin Nucl Med. 2010;35(9):704–5.
McCarville MB, Christie R, Daw NC, Spunt SL, Kaste SC. PET/CT in the evaluation of childhood sarcomas. Am J Roentgenol. 2005;184(4):1293–304.
Mirzaei S, Knoll P, Kohn H. Diagnosis of recurrent astrocytoma with fludeoxyglucose F18 PET scanning. NEJM. 2001;344:2030–1.
Niederkohr RD, Cameron MJ, French CA. FDG PET/CT imaging of NUT midline carcinoma. Clin Nucl Med. 2011;36(9):e124–6.
Nusair S, Rubinstein R, Freedman NM, Amir G, Bogot NR, Izhar U, Breuer R. Positron emission tomography in interstitial lung disease. Respirology. 2007;12(6):843–947.
Rhodes MM, Delbeke D, Whitlock JA, Martin W, Kuttesch JF, Frangoul HA, Shankar S. Utility of FDG-PET/CT in follow-Up of children treated for Hodgkin and Non-Hodgkin lymphoma. J Pediatr Hematol Oncol. 2006;28(5):300–6.
Riad R, Omar W, Kotb M, Hafez M, Sidhom I, Zamzam M, Zaky I, Abdel-Dayem H. Role of PET/CT in malignant pediatric lymphoma. Eur J Nucl Med Mol Imaging. 2010;37(2):319–29.
Sahani DV, Kalva SP. Imaging the liver. The Oncologist. 2004;9(4):385–97.
Shammas A, Lim R, Charron M. Pediatric FDG PET/CT: physiologic uptake, normal variants, and benign conditions. RadioGraphics. 2009;29:1467–86.
Shammas A, Degirmenci B, Mountz JM, McCook BM, Branstetter B, Bencherif BB, Joyce JM, Carty SE, Kuffner HA, Avril N. 18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer. J Nucl Med. 2007;48(2):221–6.
Tateishi U, Hosono A, Makimoto A, Nakamoto Y, Kaneta T, Fukuda H, Murakama K, Terauchi T, Suga T, Inoue T. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma. Ann Nucl Med. 2009;23(2):155–61.
von Falck C, Maecker B, Schirg E, Boerner AR, Knapp WH, Klein C, Galanski M. Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring. Eur J Radiol. 2007;63:427–35.
Wang K-B, Tsai S-C, Chen Y-C. A possible musculoskeletal pitfall in 18F-FDG PET: nodular fascitis. Ann Nucl Med Sci. 2010;23:165–8.
Yun M, Kim W, Alnafisi N, Lacorte L, Jang S, Alavi A. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med. 2001;42(12):1795–9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gamie, S.H., Yevdayev, E., Kaushik, A., Lai, H.A. (2016). Pediatric Imaging. In: Conti, P., Kaushik, A. (eds) PET-CT. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-5811-2_14
Download citation
DOI: https://doi.org/10.1007/978-1-4419-5811-2_14
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-5810-5
Online ISBN: 978-1-4419-5811-2
eBook Packages: MedicineMedicine (R0)